A system for determining maximum tolerated dose in clinical trial (Q5880093): Difference between revisions

@@ Property / cites work @@
+Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial
+Normal rank
@@ Property / cites work @@
+On the consistency of the continual reassessment method with multiple toxicity constraints
+Normal rank
@@ Property / cites work @@
+Semiparametric Dose Finding Methods
@@ Property / cites work: Semiparametric Dose Finding Methods / rank @@
+Normal rank
@@ Property / cites work @@
+Estimating the Probability of Toxicity at the Recommended Dose Following a Phase I Clinical Trial in Cancer
+Normal rank
@@ Property / cites work @@
+Continual reassessment designs with early termination
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
+Normal rank
@@ Property / cites work @@
+Miscellanea. A stopping rule for the continual reassessment method
+Normal rank
@@ Property / cites work @@
+Designs foe phase i cancer clinical trials with differentiation of graded toxicity
+Normal rank
@@ Property / cites work @@
+A phase I dose-finding study based on polychotomous toxicity responses
+Normal rank
@@ Property / cites work @@
+A study of the probit model with latent variables in Phase I clinical trials
+Normal rank
@@ Property / cites work @@
+The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach
+Normal rank
@@ Property / cites work @@
+Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
+Normal rank